New weapon fights drug-resistant tumors
Biologists identify a drug that can help wipe out reservoirs of cancer cells in bone marrow.
Ludwig Cancer Research gives $90 million to MIT
MIT is one of six institutions receiving a total of $540 million to provide reliable, long-term support for high-impact, innovative research.
New sensor tracks zinc in cells
Shifts in zinc’s location could be exploited for early diagnosis of prostate cancer.
MIT Center for Integrative Synthetic Biology receives five-year NIH grant
Five-year grant will support research on cancer therapy, artificial tissue homeostasis, and infectious diseases.
Biologists ID new cancer weakness
Drugs that block new target gene could make many tumors more vulnerable to chemotherapy.
Resistance is futile
Chemists develop new way to kill cancer cells resistant to the chemotherapy drug cisplatin.
One-two punch knocks out aggressive tumors
New nanoparticles weaken tumor-cell defenses, then strike with chemotherapy drug.
Nanoparticle vaccine offers better protection
Particles that deliver vaccines directly to mucosal surfaces could defend against many infectious diseases.
Watching tumors burst through a blood vessel
A microfluidic platform provides a high-resolution view of a crucial step in cancer metastasis.
Why tumors become drug-resistant
New findings could lead to drugs that fight back when tumors don’t respond to treatment.
Research points toward better colonoscopy
New technology offers three-dimensional images, making it easier to detect precancerous lesions.
Nanoparticles, made to order — inside and out
New research enables high-speed customization of novel nanoparticles for drug delivery and other uses.
Grad student receives grant for melanoma research
David Benjamin will investigate mechanisms that melanoma cells use to spread to distant sites throughout the body
Study IDs key protein for cell death
Findings may offer a new way to kill cancer cells by forcing them into an alternative programmed-death pathway.
A different view of cancer cells
New study measures physical changes in tumor cells as they become metastatic.